首页 | 本学科首页   官方微博 | 高级检索  
检索        

伯氏鼠疟原虫(Plasmodium berghei)对咯萘啶抗药性的研究
引用本文:邵葆若,叶秀玉,郑浩.伯氏鼠疟原虫(Plasmodium berghei)对咯萘啶抗药性的研究[J].药学学报,1982,17(8):566-571.
作者姓名:邵葆若  叶秀玉  郑浩
作者单位:中国医学科学院寄生虫病研究所,上海
摘    要:用本所传代已二十余年、对药物敏感的伯氏鼠疟原虫作种源,每转种一代给小白鼠口服单次量咯萘啶。第1代剂量为8 mg/kg,其后剂量每代增加2 mg/kg。转种至第23代,剂量达2,400mg/kg时,虽部分小鼠死亡,存活小鼠的原虫血症仍不转阴,此时原虫的抗药性为亲代原虫的300倍以上。抗咯萘啶鼠疟原虫(RPB2)对氯喹、喹哌、吡咯喹、M-6407、阿的平与青蒿素等有一定程度的交叉抗药性。用对亲代原虫有效量的3~10倍治疗RPB2原虫时,不能使原虫血症转阴。如不再用药,连续转种5代,RPB2可恢复对咯萘啶的敏感性。

关 键 词:疟疾  疟原虫  伯氏鼠疟原虫  抗疟药  裂殖体杀灭剂  抗药性  交叉抗性  咯萘啶  氯喹  青蒿素
收稿时间:1981-08-20

DEVELOPMENT OF PYRONARIDINE-RESISTANE IN PLASMODIUM BERGHEI
SHAO Bao-ruo,YE Xiu-yu and ZHENG Hao.DEVELOPMENT OF PYRONARIDINE-RESISTANE IN PLASMODIUM BERGHEI[J].Acta Pharmaceutica Sinica,1982,17(8):566-571.
Authors:SHAO Bao-ruo  YE Xiu-yu and ZHENG Hao
Abstract:Drug-sensitive P. berghei maintained by syringe passage for over 20 years was passed successively to clean mice under increasing selection pressure of pyronaridine base. Of the 5 mice administered single oral doses of 8 mg/kg (1.2 times its ED50) in Passage 1, four mice were free from parasitemia 3~4 days after drug administration. From passage 2 onwards, an escalation of 2 mg/kg of pyronaridine per passage was performed. Five mice of Passage 2 were dosed with 10 mg/kg, but their parasitemia remained positive, This result suggested the commencement of drug resistance. By Passage 23, which was reached in about 5 1/2 months, a test dose of 2, 400 mg/kg (1.8 times its LD50) was given to a group of mice to assess the drug sensitivity. Though some of the mice died of the dosage, none of the survivors was free of plasmodium parasite. It was evident that a pyronaridine-resistant line of P. berghei was fully developed as the parasites could tolerate a higher dose of pyronaridine than the hosts, bearing approximately a 300-fold resistance to pyronaridine when compared with the parent line.The virulence of pyronaridine-resistant line was much lower than that of its parent line. The sensitivity of pyronaridine-resistant line to 6 erythrocytic schizontocides chloroquine, piperaquinoline, amopyroquine, M-6407 (a 4-aminoquinoline), mepacrine, qinghaosu] was also decreased significantly. By testing these drugs at doses over 3~10 times those effective to the parent line parasites, pyronaridine-resistant line failed to respond to the 6 drugs, indicating the presence of cross resistance of pyronaridine-resistant line to the 6 schizontocidal agents. However, when the pyronaridine pressure was lifted for 5 passages, the pyronaridine-resistant line was reverted to a pyronaridine sensitive line.
Keywords:Plasmodium parasite  Plasmodium berghei  Antimalarials  Blood sehizontocide  Drug resistance  Cross resistance  Pyronaridine  Chloroquine  Qinghaosu  Malaria
点击此处可从《药学学报》浏览原始摘要信息
点击此处可从《药学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号